(S)-2-(Morpholin-2-yl)acetic acid hydrochloride, 95.0%, 100mg

Methyl-4-amino-3-fluorobenzoate, 98.0%, 500g

N-(5-Chloro-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)propan-2-amine, 97%, 1g

{[4-(6-Dimethylamino-4-trifluoromethyl-pyridin-2-yl)-benzyl]-methyl-amino}-acetic acid, 95.0%, 1g

2-(6-Methylpyridin-3-yl)propan-2-ol, 97%, 5g

Cyclohexanol, min. 99%, for synthesis, 1L, glass packaging

tert-butyl 2-aminoisonicotinate, 95.0%, 500mg

2-(4-Hydroxyphenyl)-N,N-dimethylethylamine hydrochloride, 97.0%, 5g

(S)-(4-(1-AMINOETHYL)PHENYL)METHANOL, 95.0%, 50mg

N-(1H-1,2,3-Benzotriazol-1-ylmethyl)-N-(furan-2-ylmethyl)aniline, 10mg

2-Butanone oxime, 5g

(4-Bromo-2-methoxyphenyl)boronic acid, 95.0%, 1g

3-(2-Chloropyrimidin-4-yl)-1-cyclopropyl-1H-indole, 97.0%, 1g